Wed, Nov 21, 2018
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Private Equity Strategies

Dealmakers Q&A: MedMen eye second fund

Friday, September 29, 2017

By: Bailey McCann, Private Equity Strategies

Los Angeles, California-based cannabis-focused investment firm MedMen is eying its second fund. The firm is targeting $250 million for investments in cannabis assets.

MedMen's investor base is largely high net worth individuals and family offices, but the firm has also had some institutional interest. MedMen partnered with Chicago-based Wicklow Capital, a venture capital firm, for investments from its first fund which closed on just under $100 million earlier this year. Wicklow Capital is backed by Dan Tierney, the co-founder and former board member of GETCO, a Chicago-based high-frequency trading firm, now known as KCG Holdings following GETCO's acquisition of Knight Capital in 2013. MedMen typically invests between $1-40 million per transaction and made seven investments from its debut fund.

Unlike other cannabis industry investors that are focused on investing in existing consumer distributors, MedMen invests in raw assets. The firm is looking for opportunities to buy licenses or cannabis assets that they can then turn into an enterprise. MedMen operates by using a management holding company model, so they are the owners of each entity in the portfolio, rather than simply investing in several companies.

"We made a strategic decision to be very hands-on with development," MedMen co-Chairman and Partner, Chris Leavy tells Private Equity Strategies. Leavy oversees the investment strategy for the firm. Prior to joining MedMen, Leavy spent more than two decades on Wall Street, holding senior management roles at Morgan Stanley, OppenheimerFunds, and BlackRock.

According to Leavy, the development model MedMen uses is more resource intensive, but it allows the firm to be a prime mover in the still nascent industry. "We are working on everything from regulatory, to site selection, to bringing in people with relevant experience," he explains. "Many people look at us as a pot business, but we are largely working with experts from other fields including agriculture, chemistry, consumer marketing, finance. We are creating a new industry."

MedMen has an established presence in states that allow medical marijuana and is expanding its footprint into emerging medical markets including Massachusetts, New York, and Nevada.

In some ways, the firm operates like a large mid-market specialist private equity manager. Because of the focus on a single industry, Leavy and the investment team can take advantage of common private equity scaling practices like group purchasing, group marketing, and supply chain optimization. For Leavy, that model is key to MedMen's growth prospects because he says, it creates standardization and opportunity in an otherwise inefficient and fragmented market. "We're still early enough into the development of the industry that people are trying a lot of different models," he says. "This isn't available in every state. So if we can come in and build scale, there is opportunity for us there."

 
This article was published in Opalesque's Private Equity Strategies our monthly research update on the global private equity landscape including all sectors and market caps.
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies


Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. M&A: SS&C completes $1.5bn takeover of Intralinks[more]

    SS&C Technologies Holdings, a global provider of financial services software and software-enabled services, today announced it has completed the acquisition of Intralinks Holdings, Inc. Intralinks is a leading financial technology provider for the global banking, deal making and capital markets comm

  2. Institutional Investors: Hedge funds in, equities out at San Francisco pension plan, Investcorp launches business to take minority stakes in midsize alts firms, Kempen Capital Management wins $9.7bn mandate as fiduciary manager, Brunel eyes $1.66bn emerging markets equities allocation, MOSERS issues RFP for illiquid alts specialty consultant[more]

    Hedge funds in, equities out at San Francisco pension plan From CIO: San Francisco Employees' Retirement System CIO William Coaker Jr. says his 2-year-old plan to restructure the system's $24.5 billion portfolio away from public equities while increasing allocations to hedge funds and p

  3. Performance: Hedge funds reap windfalls from market rout, Joel Greenblatt's flagship fund has beaten 99% of competitors over the past 3 years, Renault sell-off drives profits for quant hedge fund, Hedge funds Odey, GLG are exposed as spread-betters bounce back[more]

    Hedge funds reap windfalls from market rout From FT: The stock market correction of the past two months has been painful for many investors, but a small group of bearish hedge fund managers believe their time has arrived. These traders, who have been positioned for a slump and suf

  4. Tax: Hedge fund investors lose key tax break for management expenses[more]

    From Accounting Today: For some hedge fund investors, President Donald Trump's tax overhaul adds insult to the injury from poor investment performance. The Republican law eliminates deductions for certain expenses that wealthy taxpayers previously could itemize on their returns, including the

  5. U.S.: Hedge funds' historic bond bet swing suggests Fed close to cycle end, Goldman Sachs believes the US economy will slow to a crawl next year[more]

    Hedge funds' historic bond bet swing suggests Fed close to cycle end From Reuters: A potentially huge shift is underway in the U.S. bond market, underscored by a historic swing in hedge fund positions: investors are beginning to think the U.S. economy is close to peaking and the Fed is ne